Titre
Overview about Candida auris: What's up 12 years after its first description?
Type
synthèse (review)
Institution
UNIL/CHUV/Unisanté + institutions partenaires
Périodique
Auteur(s)
Desoubeaux, G.
Auteure/Auteur
Coste, A.T.
Auteure/Auteur
Imbert, C.
Auteure/Auteur
Hennequin, C.
Auteure/Auteur
Liens vers les personnes
Liens vers les unités
ISSN
1773-0449
Statut éditorial
Publié
Date de publication
2022-05
Volume
32
Numéro
2
Première page
101248
Peer-reviewed
Oui
Langue
anglais
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Publication Status: ppublish
Résumé
Candida auris has been described as an emerging yeast species during the last decade. As many as 25% of its strains may naturally exhibit multi-drug resistance to the currently available antifungal drugs. Probably due to its ability to survive more than two weeks on inert surfaces, several large outbreaks have been reported, primarily due to nosocomial transmissions. In addition, due to a rapid worldwide spreading, C. auris is now considered as a major public health threat. This review aims at describing the current knowledge about C. auris, with specific focuses on its global epidemiology, virulence features, most reliable diagnostic approaches, and the current and future therapeutic options.
PID Serval
serval:BIB_8590DF26BAD7
PMID
Date de création
2022-02-08T07:56:34.068Z
Date de création dans IRIS
2025-05-21T01:43:01Z